TY - JOUR AU - Bani-Sadr, F. AU - Denoeud, L. AU - Morand, P. AU - Lunel-Fabiani, F. AU - Pol, S. AU - Cacoub, P. PY - 2007 DA - 2007// TI - Early virologic failure in HIV-coinfected hepatitis C patients treated with the peginterferon-ribavirin combination: does abacavir play a role? JO - J Acquir Immune Defic Syndr VL - 45 UR - https://doi.org/10.1097/QAI.0b013e318040b2b6 DO - 10.1097/QAI.0b013e318040b2b6 ID - Bani-Sadr2007 ER - TY - JOUR AU - Mira, J. A. AU - Lopez-Cortes, L. F. AU - Barreiro, P. AU - Tural, C. AU - Torres-Tortosa, M. AU - Los SG, I. PY - 2008 DA - 2008// TI - Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone JO - J Antimicrob Chemother VL - 62 UR - https://doi.org/10.1093/jac/dkn420 DO - 10.1093/jac/dkn420 ID - Mira2008 ER - TY - JOUR AU - Vispo, E. AU - Barreiro, P. AU - Pineda, J. A. AU - Mira, J. A. AU - Maida, I. AU - Martin-Carbonero, L. PY - 2008 DA - 2008// TI - Low response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C treated with abacavir JO - Antivir Ther VL - 13 ID - Vispo2008 ER - TY - JOUR AU - Glue, P. PY - 1999 DA - 1999// TI - The clinical pharmacology of ribavirin JO - Semin Liver Dis VL - 19 ID - Glue1999 ER - TY - JOUR AU - Pineda, J. A. AU - Mira, J. A. AU - Gil, I. L. AU - Valera-Bestard, B. AU - Rivero, A. AU - Merino, D. PY - 2007 DA - 2007// TI - Influence of concomitant antiretroviral therapy on the rate of sustained virological response to pegylated interferon plus ribavirin in hepatitis C virus/HIV-coinfected patients JO - J Antimicrob Chemother VL - 60 UR - https://doi.org/10.1093/jac/dkm373 DO - 10.1093/jac/dkm373 ID - Pineda2007 ER - TY - JOUR AU - Laufer, N. AU - Laguno, M. AU - Perez, I. AU - Cifuentes, C. AU - Murillas, J. AU - Vidal, F. PY - 2008 DA - 2008// TI - Abacavir does not influence the rate of virological response in HIV-HCV-coinfected patients treated with pegylated interferon and weight-adjusted ribavirin JO - Antivir Ther VL - 13 ID - Laufer2008 ER - TY - JOUR AU - Amorosa, V. K. AU - Slim, J. AU - Mounzer, K. AU - Bruno, C. AU - Hoffman-Terry, M. AU - Dorey-Stein, Z. PY - 2010 DA - 2010// TI - The influence of abacavir and other antiretroviral agents on virological response to HCV therapy among antiretroviral-treated HIV-infected patients JO - Antivir Ther VL - 15 UR - https://doi.org/10.3851/IMP1492 DO - 10.3851/IMP1492 ID - Amorosa2010 ER - TY - JOUR AU - Solas, C. AU - Pambrun, E. AU - Winnock, M. AU - Salmon, D. AU - Poizot-Martin, I. AU - Dominguez, S. PY - 2012 DA - 2012// TI - Ribavirin and abacavir drug interaction in HIV-HCV coinfected patients: fact or fiction? JO - AIDS VL - 26 UR - https://doi.org/10.1097/QAD.0b013e32835763a4 DO - 10.1097/QAD.0b013e32835763a4 ID - Solas2012 ER - TY - JOUR AU - Berenguer, J. AU - Wichmann, M. A. AU - Quereda, C. AU - Miralles, P. AU - Mallolas, J. AU - Lopez-Aldeguer, J. PY - 2011 DA - 2011// TI - Effect of accompanying antiretroviral drugs on virological response to pegylated interferon and ribavirin in patients co-infected with HIV and hepatitis C virus JO - J Antimicrob Chemother VL - 66 UR - https://doi.org/10.1093/jac/dkr362 DO - 10.1093/jac/dkr362 ID - Berenguer2011 ER - TY - JOUR AU - Wai, C. T. AU - Greenson, J. K. AU - Fontana, R. J. AU - Kalbfleisch, J. D. AU - Marrero, J. A. AU - Conjeevaram, H. S. PY - 2003 DA - 2003// TI - A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C JO - Hepatology VL - 38 UR - https://doi.org/10.1053/jhep.2003.50346 DO - 10.1053/jhep.2003.50346 ID - Wai2003 ER - TY - JOUR AU - Hoggard, P. G. AU - Kewn, S. AU - Barry, M. G. AU - Khoo, S. H. AU - Back, D. J. PY - 1997 DA - 1997// TI - Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitro JO - Antimicrob Agents Chemother VL - 41 ID - Hoggard1997 ER - TY - JOUR AU - Nunez, M. AU - Ocampo, A. AU - Aguirrebengoa, K. AU - Cervantes, M. AU - Pascual, A. AU - Echeverria, S. PY - 2008 DA - 2008// TI - Incidence of anaemia and impact on sustained virological response in HIV/HCV-coinfected patients treated with pegylated interferon plus ribavirin JO - J Viral Hepat VL - 15 UR - https://doi.org/10.1111/j.1365-2893.2007.00952.x DO - 10.1111/j.1365-2893.2007.00952.x ID - Nunez2008 ER - TY - CHAP PY - 2014 DA - 2014// TI - EACS Guidelines version7.02, June 2014 BT - European AIDS Clinical Society ID - ref13 ER - TY - JOUR AU - Sulkowski, M. S. AU - Wasserman, R. AU - Brooks, L. AU - Ball, L. AU - Gish, R. PY - 2004 DA - 2004// TI - Changes in haemoglobin during interferon alpha-2b plus ribavirin combination therapy for chronic hepatitis C virus infection JO - J Viral Hepat VL - 11 UR - https://doi.org/10.1111/j.1365-2893.2004.00490.x DO - 10.1111/j.1365-2893.2004.00490.x ID - Sulkowski2004 ER - TY - JOUR AU - Rockstroh, J. K. AU - Peters, L. AU - Grint, D. AU - Soriano, V. AU - Reiss, P. AU - Monforte, A. PY - 2013 DA - 2013// TI - Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV? JO - J Hepatol VL - 59 UR - https://doi.org/10.1016/j.jhep.2013.04.005 DO - 10.1016/j.jhep.2013.04.005 ID - Rockstroh2013 ER - TY - JOUR AU - Opravil, M. AU - Rodriguez-Torres, M. AU - Rockstroh, J. AU - Snoeck, E. AU - Chung, R. T. AU - Tietz, A. PY - 2012 DA - 2012// TI - The dose–response relationship of peginterferon alfa-2a and ribavirin in the treatment of patients coinfected with HIV-HCV JO - HIV Clin Trials VL - 13 UR - https://doi.org/10.1310/hct1301-33 DO - 10.1310/hct1301-33 ID - Opravil2012 ER - TY - JOUR AU - Sulkowski, M. S. AU - Shiffman, M. L. AU - Afdhal, N. H. AU - Reddy, K. R. AU - McCone, J. AU - Lee, W. M. PY - 2010 DA - 2010// TI - Hepatitis C virus treatment-related anemia is associated with higher sustained virologic response rate JO - Gastroenterology VL - 139 UR - https://doi.org/10.1053/j.gastro.2010.07.059 DO - 10.1053/j.gastro.2010.07.059 ID - Sulkowski2010 ER - TY - JOUR AU - Nunez, M. AU - Camino, N. AU - Ramos, B. AU - Berdun, M. A. AU - Barreiro, P. AU - Losada, E. PY - 2005 DA - 2005// TI - Impact of ribavirin exposure on early virological response to hepatitis C therapy in HIV-infected patients with chronic hepatitis C JO - Antivir Ther VL - 10 ID - Nunez2005 ER - TY - JOUR AU - Soriano, V. AU - Puoti, M. AU - Sulkowski, M. AU - Cargnel, A. AU - Benhamou, Y. AU - Peters, M. PY - 2007 DA - 2007// TI - Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel JO - AIDS VL - 21 UR - https://doi.org/10.1097/QAD.0b013e3281084e4d DO - 10.1097/QAD.0b013e3281084e4d ID - Soriano2007 ER - TY - JOUR AU - Carrat, F. AU - Bani-Sadr, F. AU - Pol, S. AU - Rosenthal, E. AU - Lunel-Fabiani, F. AU - Benzekri, A. PY - 2004 DA - 2004// TI - Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial JO - JAMA VL - 292 UR - https://doi.org/10.1001/jama.292.23.2839 DO - 10.1001/jama.292.23.2839 ID - Carrat2004 ER - TY - JOUR AU - Smit, C. AU - Berg, C. AU - Geskus, R. AU - Berkhout, B. AU - Coutinho, R. AU - Prins, M. PY - 2008 DA - 2008// TI - Risk of hepatitis-related mortality increased among hepatitis C virus/HIV-coinfected drug users compared with drug users infected only with hepatitis C virus: a 20-year prospective study JO - J Acquir Immune Defic Syndr VL - 47 UR - https://doi.org/10.1097/QAI.0b013e31815d2f59 DO - 10.1097/QAI.0b013e31815d2f59 ID - Smit2008 ER - TY - JOUR AU - Graham, C. S. AU - Baden, L. R. AU - Yu, E. AU - Mrus, J. M. AU - Carnie, J. AU - Heeren, T. PY - 2001 DA - 2001// TI - Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis JO - Clin Infect Dis VL - 33 UR - https://doi.org/10.1086/321909 DO - 10.1086/321909 ID - Graham2001 ER - TY - JOUR AU - Labarga, P. AU - Vispo, E. AU - Barreiro, P. AU - Rodriguez-Novoa, S. AU - Pinilla, J. AU - Morello, J. PY - 2010 DA - 2010// TI - Rate and predictors of success in the retreatment of chronic hepatitis C virus in HIV/hepatitis C Virus coinfected patients with prior nonresponse or relapse JO - J Acquir Immune Defic Syndr VL - 53 UR - https://doi.org/10.1097/QAI.0b013e3181bd5ce1 DO - 10.1097/QAI.0b013e3181bd5ce1 ID - Labarga2010 ER -